SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020538
Filing Date
2021-04-26
Accepted
2021-04-26 16:22:37
Documents
5
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A cccc-def14a_20210615.htm DEF 14A 951643
2 GRAPHIC gesblqamtibd000003.jpg GRAPHIC 3953
3 GRAPHIC gesblqamtibd000004.jpg GRAPHIC 3953
4 GRAPHIC gesblqamtibd000002.jpg GRAPHIC 19860
5 GRAPHIC gesblqamtibd000001.jpg GRAPHIC 38962
  Complete submission text file 0001564590-21-020538.txt   1045185
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39567 | Film No.: 21854126
SIC: 2836 Biological Products, (No Diagnostic Substances)